Our Ingress-health team helps you understand at an early stage what economically justifiable price (EJP) is of your product and which variables drive this price
Depending on your needs, the Ingress-health team can develop pragmatic health-economic models that can be used to estimate your product’s EJP and help identify the variables that influence the EJP. We can also develop more advanced models that can later be extended to a core health-economic model. Besides EJP analyses, the early models that we develop can also help you optimize your trial design for reimbursement purposes and the outcomes can also support “go/no go” decisions.
By completing your details below you are agreeing to receive communications and updates from us including but not limited to news, the latest publications, and invitations to Ingress-Health company events.